NRX Pharmaceuticals, Inc. Common Stock, Value, Issued
NRX Pharmaceuticals, Inc. (NRXP) had Common Stock, Value, Issued of $43.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $43.00K.
- 2026-03-31: Common Stock, Value, Issued $33.00K.
- 2025-12-31: Common Stock, Value, Issued $32.00K.
- 2025-09-30: Common Stock, Value, Issued $28.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $43.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $33.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $32.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $28.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $19.00K 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $17.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $15.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $11.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $11.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $10.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $8.00K 10-K · filed 2025-03-14 | $84.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $84.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $80.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $70.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $67.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $68.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $67.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $67.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $59.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $54.81K 10-Q/A · filed 2022-08-12 | |
| 2021-06-30 | $48.60K 10-Q/A · filed 2022-08-12 | |
| 2021-03-31 | $2.69K 10-Q · filed 2021-05-21 | |
| 2020-12-31 | $42.97K 10-Q/A · filed 2022-08-12 | $2.69K 10-K · filed 2021-04-01 |
| 2020-09-30 | $2.69K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.72K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.72K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.84K 10-K/A · filed 2021-05-14 | |
| 2019-09-30 | $2.81K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.80K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.79K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.73K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $2.64K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.62K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.61K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.59K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |